artesunic acid has been researched along with Neoplasms in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 15 (51.72) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, T; Li, Y; Peng, Y; Tan, W; Tan, Y; Wang, XQ; Xuan, W | 1 |
| Chen, M; Wong, KH; Xu, F; Zhao, N; Zhong, W | 1 |
| Chen, J; Du, M; Gu, L; Liu, D; Liu, S; Peng, Q; Shen, S; Tian, Y; Wang, J; Xiao, W; Zhang, J | 1 |
| Chen, M; Huang, D; Kappen, M; Lin, F; Liu, S; Lu, J; Lu, L; Lu, S; Luo, X; Wang, Y; Xiong, G; You, C; Yu, S; Yu, Y | 1 |
| Feng, Y; Li, N; Wang, K; Zhao, C; Zhao, L; Zhou, Y | 1 |
| Dong, S; Jiang, Y; Li, X; Liu, C; Wang, J; Wang, Y; Zha, W | 1 |
| Dai, QL; Jia, HJ; Rui Bai, S; Wang, XB; Xia, J; Yue He, S; Zhou, M | 1 |
| Chen, Y; Guan, N; Hu, Y; Wu, J; Xiong, S; Xu, H; Ye, Q | 1 |
| Chen, XL; Huang, QF; Huang, ZJ; Jun, M; Li, YH; Wang, GH; Wang, W | 1 |
| AlHilli, M; Beffa, L; Belinson, JL; Brainard, J; Debernardo, R; Michener, CM; Plesa, M; Ricci, S; Trimble, CL; Waggoner, SE | 1 |
| Bertzbach, LD; Conradie, AM; Hahn, F; Kaufer, BB; Marschall, M; Wild, M | 1 |
| Jiang, Z; Liu, Y; Tao, L; Xu, M; Xu, T | 1 |
| Fan, Z; Ge, D; Han, J; Hou, Z; Huang, D; Jiang, B; Su, G; Tu, L; Xiang, S; Yang, Y; Zhao, Q; Zhu, Q | 1 |
| Chen, WJ; Lin, N; Mao, X; Zhang, YQ | 1 |
| Abdelfatah, S; Efferth, T; Fischer, N; Fleischer, E; Klinger, A; Seo, EJ | 1 |
| Chen, J; Fan, L; Gao, L; Huang, Y; Qian, X; Xi, J; Zhang, J | 1 |
| Adah, D; Chen, X; Hu, W; Qin, L | 1 |
| Chen, Q; Guo, Z; Li, L; Li, T; Tu, J; Wang, X; Wu, H; Xu, P; Zhang, L; Zhang, R | 1 |
| Cheema, AK; Deeken, JF; Giaccone, G; Hartley, M; He, AR; Hwang, JJ; Liu, S; Luecht, J; Marshall, JL; Pishvaian, MJ; Smaglo, B; Spiegel, JY; Wang, H; Weiner, LM | 1 |
| Huang, D; Lee, YM; Lu, L; Sun, X; Wang, J; Wang, L; Wong, YK; Wu, G; Yang, L; Zhang, J; Zhao, T; Zhong, J; Zhou, C | 1 |
| Fan, X; Xia, X; Zhao, M; Zhu, P | 1 |
| Ng, S; Shen, HM; Shi, Y; Tan, KS; Tan, SH; Wong, WS; Yang, ND; Zhou, J | 1 |
| Gannon, S; Murphy, JE; Murray, J; Rawe, S | 1 |
| Liu, XL; Wang, S; Xu, LL; Xu, N; Zhou, HS; Zhou, X | 1 |
| Efferth, T; Konkimalla, VB; McCubrey, JA | 1 |
| Efferth, T; Eichhorn, T; Plinkert, PK; Sauer, A; Sertel, S; Sieber, S; Weiss, J | 1 |
| Efferth, T; Hoheisel, JD; Youns, M | 1 |
| Berdelle, N; Efferth, T; Kaina, B; Nikolova, T; Quiros, S | 1 |
| Chitambar, CR; Dunstan, H; Efferth, T; Miyachi, H; Sauerbrey, A | 1 |
4 review(s) available for artesunic acid and Neoplasms
| Article | Year |
|---|---|
[Current research analysis and prospects on sensitization effect of artesunate on anti-cancer radiotherapy and chemotherapy].
Topics: Artesunate; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Humans; Neoplasms; Radiation-Sensitizing Agents | 2019 |
The mechanisms of action of Plasmodium infection against cancer.
Topics: Animals; Artesunate; Cell Proliferation; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Malaria; Mice; Neoplasms; Tumor Microenvironment | 2021 |
The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
Topics: Apoptosis; Artesunate; Autophagy; Cell Death; Ferroptosis; Humans; Iron; Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Reactive Oxygen Species; Sulfasalazine | 2019 |
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Artemisinins; Artesunate; Berberine; Biological Products; Cantharidin; Complementary Therapies; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Models, Biological; Neoplasms; Oxides | 2010 |
1 trial(s) available for artesunic acid and Neoplasms
| Article | Year |
|---|---|
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.
Topics: Administration, Intravenous; Adult; Antineoplastic Agents; Area Under Curve; Artesunate; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting | 2018 |
24 other study(ies) available for artesunic acid and Neoplasms
| Article | Year |
|---|---|
A new paradigm for artesunate anticancer function: considerably enhancing the cytotoxicity via conjugating artesunate with aptamer.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Artesunate; HCT116 Cells; Humans; K562 Cells; Neoplasms | 2021 |
NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy.
Topics: Artesunate; Calcium Carbonate; Cell Line, Tumor; Doxorubicin; Humans; Indoles; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy; Polymers; Reactive Oxygen Species | 2022 |
Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy.
Topics: Animals; Artemisinins; Artesunate; Female; Humans; Liposomes; Mice; Mitochondria; Neoplasms; Prodrugs | 2022 |
Near-Infrared-II Light Induced Mild Hyperthermia Activate Cisplatin-Artemisinin Nanoparticle for Enhanced Chemo/Chemodynamic Therapy and Immunotherapy.
Topics: Animals; Artemisinins; Artesunate; Cisplatin; Humans; Hyperthermia, Induced; Immunotherapy; Mice; Nanoparticles; Neoplasms; Prodrugs; Serum Albumin, Human; Tumor Microenvironment | 2022 |
Artesunate ameliorates osteoarthritis cartilage damage by updating MTA1 expression and promoting the transcriptional activation of LXA4 to suppress the JAK2/STAT3 signaling pathway.
Topics: Aggrecans; Animals; Artesunate; Cartilage; Chondrocytes; Collagen; Interleukin-1beta; Mice; Neoplasms; Osteoarthritis; Signal Transduction; Transcriptional Activation | 2023 |
Local delivery of artesunate dimer liposomes incorporated injectable hydrogel for H
Topics: Alginates; Animals; Artesunate; Cell Line, Tumor; Glutathione; Hemin; Hydrogels; Hydrogen Peroxide; Hydrogen-Ion Concentration; Liposomes; Mice; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |
Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity.
Topics: Animals; Artesunate; Camptothecin; Cellular Senescence; Humans; Intestinal Diseases; Irinotecan; Mice; Neoplasms; TOR Serine-Threonine Kinases | 2023 |
Flagella of Tumor-Targeting Bacteria Trigger Local Hemorrhage to Reprogram Tumor-Associated Macrophages for Improved Antitumor Therapy.
Topics: Artesunate; Bacteria; Flagella; Hemorrhage; Humans; Neoplasms; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer.
Topics: Artesunate; Biological Availability; Ferroptosis; Humans; Hyaluronic Acid; Lipid Peroxides; Neoplasms; Reactive Oxygen Species | 2023 |
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Topics: Artesunate; Biopsy; Carcinoma in Situ; Female; Humans; Neoplasms; Papillomavirus Infections; Prospective Studies; Vulvar Neoplasms | 2023 |
Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus.
Topics: Alphaherpesvirinae; Animals; Antiviral Agents; Artesunate; Cell Transformation, Viral; Herpesviridae Infections; Incidence; Neoplasms; Poultry Diseases; Virus Replication | 2019 |
Induction of APOBEC3C Facilitates the Genotoxic Stress-Mediated Cytotoxicity of Artesunate.
Topics: Animals; Antineoplastic Agents; Artesunate; Cell Line, Tumor; Cell Proliferation; Cytidine Deaminase; DNA; DNA Damage; Female; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Heterografts; Histones; Humans; Mice, Inbred BALB C; Neoplasms; Up-Regulation | 2019 |
Tumor-Specific Endogenous Fe
Topics: Animals; Antineoplastic Agents; Artesunate; Cell Line, Tumor; Cell Survival; Drug Carriers; Ferrous Compounds; Gadolinium; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Methotrexate; Mice; Mice, Nude; Nanoparticles; Neoplasms; Rats; Reactive Oxygen Species; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2020 |
A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy.
Topics: Antineoplastic Agents; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Computer Simulation; Databases, Pharmaceutical; Dose-Response Relationship, Drug; Drugs, Investigational; Humans; Ligands; Molecular Docking Simulation; Neoplasms; Tumor Protein, Translationally-Controlled 1 | 2021 |
Artesunate-loaded poly (lactic-co-glycolic acid)/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy.
Topics: Animals; Artesunate; Catalysis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Indoles; Magnetic Resonance Imaging; Manganese Compounds; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Oxides; Oxidoreductases; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2021 |
Bioinspired Microenvironment Responsive Nanoprodrug as an Efficient Hydrophobic Drug Self-Delivery System for Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Artesunate; Cell Line, Tumor; Drug Carriers; Hemolysis; Histidine; Humans; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Prodrugs; Proof of Concept Study | 2021 |
Artesunate-induced mitophagy alters cellular redox status.
Topics: Antimalarials; Antineoplastic Agents; Apoptosis; Artesunate; Drug Repositioning; HeLa Cells; Humans; Mitochondria; Mitophagy; Neoplasms; Oxidation-Reduction | 2018 |
Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin.
Topics: Antimalarials; Artemisinins; Artesunate; Cell Death; Ferritins; HeLa Cells; Hep G2 Cells; Humans; Iron; Lysosomes; Neoplasm Proteins; Neoplasms; Nuclear Receptor Coactivators; Proteolysis; Vacuolar Proton-Translocating ATPases | 2014 |
In vitro oxygen availability modulates the effect of artesunate on HeLa cells.
Topics: Antineoplastic Agents; Artemisinins; Artesunate; Cell Adhesion; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Electric Impedance; HeLa Cells; Humans; Neoplasms; Oxygen | 2014 |
Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway.
Topics: Antigens, CD; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; beta Catenin; Cadherins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Signal Transduction | 2015 |
The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells.
Topics: Artemisinins; Artesunate; Cell Line; ErbB Receptors; Humans; Neoplasms; Signal Transduction | 2009 |
Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Topics: Antimalarials; Antineoplastic Agents, Phytogenic; Artemisinins; Artesunate; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasms | 2010 |
Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; DNA-Binding Proteins; Drug Evaluation, Preclinical; Humans; Models, Biological; Neoplasms; Oxidative Stress; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation | 2011 |
The anti-malarial artesunate is also active against cancer.
Topics: Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Cell Cycle Proteins; Cell Division; Cyclin G; Cyclin G1; Cyclins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Leukemia; Neoplasms; Poly-ADP-Ribose Binding Proteins; Proteins; Rhodamines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sesquiterpenes; Tripeptidyl-Peptidase 1; Tumor Cells, Cultured | 2001 |